⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

Official Title: Prospective Evaluation of Pelvic Exenteration in Patients With Recurrent Cervical Cancer

Study ID: NCT00217633

Study Description

Brief Summary: This phase II trial is studying how well pelvic exenteration works in treating patients with recurrent cervical cancer. Pelvic exenteration may be effective in treating recurrent cervical cancer.

Detailed Description: PRIMARY OBJECTIVE: I. Correlate progression-free survival and overall survival with tumor size, time interval between primary cancer management and pelvic exenteration, and presence or absence of pelvic sidewall fixation by clinical examination in patients with recurrent cervical cancer treated with pelvic exenteration. SECONDARY OBJECTIVES: I. Determine quality of life of patients treated with this procedure. II. Correlate quality of life with reconstructive technique (e.g., no ostomy or ≥ 1 ostomy) in patients treated with this procedure. OUTLINE: Patients undergo pelvic exenteration within 14 days after study entry. Quality of life is assessed at baseline and at 6, 12, and 24 months after surgery. After completion of study treatment, patients are followed within 30 days, every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

Colorado Gynecologic Oncology Group, Aurora, Colorado, United States

Hartford Hospital, Hartford, Connecticut, United States

The Hospital of Central Connecticut, New Britain, Connecticut, United States

Beebe Medical Center, Lewes, Delaware, United States

Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States

Georgia Regents University Medical Center, Augusta, Georgia, United States

Memorial University Medical Center, Savannah, Georgia, United States

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

Union Hospital of Cecil County, Elkton MD, Maryland, United States

University of Minnesota Medical Center-Fairview, Minneapolis, Minnesota, United States

Washington University School of Medicine, Saint Louis, Missouri, United States

The Cancer Institute of New Jersey Hamilton, Hamilton, New Jersey, United States

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Roswell Park Cancer Institute, Buffalo, New York, United States

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States

Cleveland Clinic Foundation, Cleveland, Ohio, United States

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States

Lake University Ireland Cancer Center, Mentor, Ohio, United States

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Cancer Care Associates-Midtown, Tulsa, Oklahoma, United States

Tulsa Cancer Institute, Tulsa, Oklahoma, United States

Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States

M D Anderson Cancer Center, Houston, Texas, United States

Auburn Regional Medical Center, Auburn, Washington, United States

Providence Regional Cancer System-Centralia, Centralia, Washington, United States

Saint Francis Hospital, Federal Way, Washington, United States

Saint Clare Hospital, Lakewood, Washington, United States

Providence - Saint Peter Hospital, Olympia, Washington, United States

Capital Medical Center, Olympia, Washington, United States

MultiCare Good Samaritan Hospital, Puyallup, Washington, United States

MultiCare Allenmore Hospital, Tacoma, Washington, United States

MultiCare Tacoma General Hospital, Tacoma, Washington, United States

Northwest CCOP, Tacoma, Washington, United States

Saint Joseph Medical Center, Tacoma, Washington, United States

Multicare Health System, Tacoma, Washington, United States

M D Anderson International Spain, Madrid, , Spain

Contact Details

Name: D. McMeekin

Affiliation: Gynecologic Oncology Group

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: